This trial is testing whether leucine will help increase muscle mass in people with cirrhosis, by looking at the response to leucine in cirrhotic patients compared to a control group. They will measure this by looking at the rate of protein synthesis in muscle, and how this changes in response to leucine.
1 Primary · 0 Secondary · Reporting Duration: Baseline to 90 days
32 Total Participants · 2 Treatment Groups
Primary Treatment: Balanced amino acid supplement · No Placebo Group · N/A
Age 18 - 70 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: